Cynthia Timmers to Biomarkers, Tumor
This is a "connection" page, showing publications Cynthia Timmers has written about Biomarkers, Tumor.
Connection Strength
0.144
-
Phase I Trial of Trametinib with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer. Clin Cancer Res. 2020 07 01; 26(13):3117-3125.
Score: 0.033
-
Homologous recombination and DNA repair mutations in patients treated with carboplatin and nab-paclitaxel for metastatic non-small cell lung cancer. Lung Cancer. 2019 08; 134:167-173.
Score: 0.031
-
KRAS G12V Mutation in Acquired Resistance to Combined BRAF and MEK Inhibition in Papillary Thyroid Cancer. J Natl Compr Canc Netw. 2019 05 01; 17(5):409-413.
Score: 0.031
-
A Transcriptional Signature Identifies LKB1 Functional Status as a Novel Determinant of MEK Sensitivity in Lung Adenocarcinoma. Cancer Res. 2017 01 01; 77(1):153-163.
Score: 0.026
-
Impact of Pre-Analytical Variables on Cancer Targeted Gene Sequencing Efficiency. PLoS One. 2015; 10(11):e0143092.
Score: 0.024